التفاصيل البيبلوغرافية
| العنوان: |
Neonatal outcome in polycystic ovarian syndrome patients treated with metformin during pregnancy. |
| المؤلفون: |
Kovo, Michal, Weissman, Ariel, Gur, Dvir, Levran, David, Rotmensch, Sigi, Glezerman, Marek |
| المصدر: |
Journal of Maternal-Fetal & Neonatal Medicine; Jul2006, Vol. 19 Issue 7, p415-419, 5p, 3 Charts |
| مصطلحات موضوعية: |
PREGNANCY, NEWBORN infants, POLYCYSTIC ovary syndrome, PATIENTS, NEONATAL death, OBSTETRICS |
| مستخلص: |
Objective . The present study aimed to evaluate the effect of metformin exposure during pregnancy on neonates of polycystic ovarian syndrome (PCOS) patients. Method . Neonatal outcomes of 33 women with PCOS treated with metformin during pregnancy were compared to neonatal outcomes of 66 normal healthy women in a retrospective case–control study. Results . The mean birth weight percentile of neonates exposed to metformin in utero during the first trimester was significantly lower than that of neonates delivered to normal healthy matched controls. After controlling for pregnancy complications, this observation became only marginally statistically significant. Conclusion . Although metformin is an attractive option for induction of ovulation in PCOS patients, there is a need for more evidence related to its safety during pregnancy. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Maternal-Fetal & Neonatal Medicine is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher 
Full Text Finder